Zymeworks, Inc. (ZYME)
26.61
-0.93
(-3.38%)
USD |
NASDAQ |
May 01, 16:00
26.10
-0.51
(-1.92%)
After-Hours: 20:00
Zymeworks EPS Diluted (Quarterly) : -0.547 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Royalty Pharma Plc | 0.4992 |
| Johnson & Johnson | 2.141 |
| Krystal Biotech, Inc. | 1.699 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Catalyst Pharmaceuticals, Inc. | 0.4136 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -41.21M |
| Revenue (Quarterly) | 2.515M |
| Total Expenses (Quarterly) | 43.72M |
| Enterprise Value | 1.767B |
| Gross Profit Margin (Quarterly) | 32.76% |
| Profit Margin (Quarterly) | -1.64K% |
| Earnings Yield | -4.06% |
| Normalized Earnings Yield | -4.044 |